Microglial IRF5-IRF4 regulatory axis regulates neuroinflammation after cerebral ischemia and impacts stroke outcomes
Open Access
- 31 December 2019
- journal article
- research article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences of the United States of America
- Vol. 117 (3), 1742-1752
- https://doi.org/10.1073/pnas.1914742117
Abstract
Microglial activation plays a central role in poststroke inflammation and causes secondary neuronal damage; however, it also contributes in debris clearance and chronic recovery. Microglial pro- and antiinflammatory responses (or so-called M1-M2 phenotypes) coexist and antagonize each other throughout the disease progress. As a result of this balance, poststroke immune responses alter stroke outcomes. Our previous study found microglial expression of interferon regulatory factor 5 (IRF5) and IRF4 was related to pro- and antiinflammatory responses, respectively. In the present study, we genetically modified the IRF5 and IRF4 signaling to explore their roles in stroke. Both in vitro and in vivo assays were utilized; IRF5 or IRF4 small interfering RNA (siRNA), lentivirus, and conditional knockout (CKO) techniques were employed to modulate IRF5 or IRF4 expression in microglia. We used a transient middle cerebral artery occlusion model to induce stroke and examined both acute and chronic stroke outcomes. Poststroke inflammation was evaluated with flow cytometry, RT-PCR, MultiPlex, and immunofluorescence staining. An oscillating pattern of the IRF5-IRF4 regulatory axis function was revealed. Down-regulation of IRF5 signaling by siRNA or CKO resulted in increased IRF4 expression, enhanced M2 activation, quenched proinflammatory responses, and improved stroke outcomes, whereas down-regulation of IRF4 led to increased IRF5 expression, enhanced M1 activation, exacerbated proinflammatory responses, and worse functional recovery. Up-regulation of IRF4 or IRF5 by lentivirus induced similar results. We conclude that the IRF5-IRF4 regulatory axis is a key determinant in microglial activation. The IRF5-IRF4 regulatory axis is a potential therapeutic target for neuroinflammation and ischemic stroke.Keywords
Funding Information
- HHS | NIH | National Institute of Neurological Disorders and Stroke (NS093042)
- HHS | NIH | National Institute of Neurological Disorders and Stroke (NS108779)
- HHS | NIH | National Institute of Neurological Disorders and Stroke (NS096493)
This publication has 60 references indexed in Scilit:
- Microglia Responses to Pro-inflammatory Stimuli (LPS, IFNγ+TNFα) and Reprogramming by Resolving Cytokines (IL-4, IL-10)Frontiers in Cellular Neuroscience, 2018
- Ras-Related C3 Botulinum Toxin Substrate 1 Promotes Axonal Regeneration after Stroke in MiceTranslational Stroke Research, 2018
- Depletion of microglia exacerbates postischemic inflammation and brain injuryJournal of Cerebral Blood Flow & Metabolism, 2017
- Exploring New Inflammatory Biomarkers and Pathways during LPS-Induced M1 PolarizationMediators of Inflammation, 2016
- Microglia protect against brain injury and their selective elimination dysregulates neuronal network activity after strokeNature Communications, 2016
- Microglial and macrophage polarization—new prospects for brain repairNature Reviews Neurology, 2014
- The Utility of Immunohistochemistry for the Identification of Hematopoietic and Lymphoid Cells in Normal Tissues and Interpretation of Proliferative and Inflammatory Lesions of Mice and RatsToxicologic Pathology, 2012
- Microglial Cells Contribute to Endogenous Brain Defenses after Acute Neonatal Focal StrokeJournal of Neuroscience, 2011
- Acute neuroprotection by pioglitazone after mild brain ischemia without effect on long-term outcomeExperimental Neurology, 2009
- IRFs: master regulators of signalling by Toll-like receptors and cytosolic pattern-recognition receptorsNature Reviews Immunology, 2006